The PHC Group’s
Response to



Our sincere condolences to victims of COVID-19, and we hope for the quick recovery of those who have been infected. We also offer deep gratitude towards healthcare professionals who are working at the forefront to treat patients, and everyone who is helping to support the community infrastructure.

The PHC Group is taking the best measures to prevent infections such as implementing work from home, while prioritizing the safety and health of all stakeholders including healthcare professionals, researchers, patients, and employees.Meanwhile, PHC Group companies are taking a full-scale approach to provide products and services as well as stable supply for customers and patients who rely on them.

Nobuaki Nakamura
Co-head of Life Science/Diagnostics Domain
Head of Biomedical Business Unit, PHC Corporation
*Video recorded in summer 2021

Products and Services Committed to Support Customers in Healthcare and Research


Preservation Equipment, Incubators, Experiment Systems, and Laboratory Autoclaves

PHCbi supports healthcare professionals and researchers by offering various equipment including ultra-low temperature freezers for preserving specimen from COVID-19 patients, pharmaceutical refrigerators and CO2 incubators for developing COVID-19 medicines and vaccines.

Solutions for COVID-19 vaccine storage
Link to related product

Digital Diabetes Solutions

The digital diabetes solutions provided by Ascensia Diabetes Care help people with diabetes make the most of remote consultations for their diabetes. The CONTOUR®DIABETES app links to their blood glucose monitoring system to enable them to share their blood glucose data more easily with their healthcare professionals. The Ascensia team has also been using webinars and virtual trainings to ensure healthcare professionals and people with diabetes continue to get the information they need.


Testing Services

LSI Medience Corporation has been providing COVID-19 PCR testing service since February 2020. The company is working to prepare and expand testing equipment to respond to the increase in order requests.
From December 21, 2020, PCR testing that can simultaneously detect SARS-CoV-2 and influenza nucleic acid is offered to check combined infections of flu and COVID-19.


Reducing Infection Risk with Healthcare IT

To reduce the risk of COVID-19 infection for healthcare professionals and other patients, there are increasing needs for online outpatient care and medication instructions.
PHC Corporation provides more user-friendly services in response to these requests.

The Response at PHC Group Companies

Ascensia Diabetes Care Holdings AG

COVID-19 Update from Epredia

Share this page

Twitter Facebook LinkedIn